Indian J Pharm Close
 

Figure 5: Bone phosphorus content changes. OVX also reduced bone phosphorous, the effect being reversed by genistein treatment. After drug administration for 12 weeks, bone phosphorus was 98.8, 96.9 and 95.1% of SH group. Data is expressed as the mean SE. *P < 0.05 vs SH, **P < 0.01 vs SH. L: low dose (4.5 mg/kg), M: mid-dose (9 mg/kg), H: high dose (18 mg/kg).

Figure 5: Bone phosphorus content changes. OVX also reduced bone
phosphorous, the effect being reversed by genistein treatment. After
drug administration for 12 weeks, bone phosphorus was 98.8, 96.9 and
95.1% of SH group. Data is expressed as the mean SE. *P < 0.05 vs
SH, **P < 0.01 vs SH. L: low dose (4.5 mg/kg), M: mid-dose (9 mg/kg),
H: high dose (18 mg/kg).